The Federal Government on Monday revealed that Nigeria loses between N13.3tn and N17.9tn annually as direct and indirect costs due to hepatitis, and 4,252 Nigerians die from liver cancer caused by untreated hepatitis.
Coordinating Minister of Health and Social Welfare, Prof. Muhammad Pate, who made the revelation at a press briefing to commemorate the 2025 World Hepatitis Day themed “Hepatitis: Let’s break it down,” added that Nigeria has the third-highest burden of hepatitis globally, with over 20 million people infected.
He said:
“The nation faces an overwhelming burden, with over 20 million people living with Hepatitis B and C: 18.2 million are affected by Hepatitis B, and 2.5 million by Hepatitis C. Over 8.1 per cent of the Nigerian population is infected with Hepatitis B, and despite the availability of vaccination and treatment, over 90 per cent of those infected are undiagnosed and unknowingly transmit the virus to others, including children. Symptoms are often misdiagnosed as malaria. Conditions such as fever, fatigue, and malaise are typically treated with self-medication, while the virus silently damages the liver and may progress to liver failure or cancer. Tragically, 4,252 Nigerians die each year from liver cancer caused by untreated hepatitis. The socioeconomic cost of this epidemic is staggering; Nigeria loses between N13.3 trillion and N17.9 trillion annually in direct and indirect costs.”
Represented by the Director of Public Health at the ministry, Dr. Godwin Ntadom, he disclosed that the government was flagging off a nationwide, year-long initiative tagged Project 365, a constituency-by-constituency screening, diagnosis, and treatment campaign, to eliminate Hepatitis C and interrupt the transmission of Hepatitis B in Nigeria by 2030.
According to him, other measures to be undertaken include:
- Increased budgetary support for hepatitis programmes
- Creation of a Viral Elimination Fund
- Tax incentives and regulatory reforms to encourage local pharmaceutical production
- Legislative backing for expanded access to diagnostics and treatment across all geopolitical zones
- Regulatory reforms to streamline approval processes for hepatitis-related commodities
Presidential Ambassador on viral hepatitis control/elimination in Nigeria, General Yakubu Gowon, commended the efforts of the ministry, the World Health Organization, healthcare workers, organizations, stakeholders, partners, and individuals dedicated to fighting hepatitis in the country.
Represented by Adeyeye Ajayi, he was optimistic Nigeria could overcome the barriers of stigma, misinformation, and limited access to testing and treatment of hepatitis:
“Let us reaffirm our commitment to eliminating viral hepatitis by 2030. I urge everyone to join hands in this fight, promoting awareness, education, and collective action. May World Hepatitis Day 2025 inspire hope, unity, and progress toward a hepatitis-free Nigeria and the world over.”
National Coordinator of the Africa CDC, Dr. Oluyinka Olayemi, acknowledged the efforts of key stakeholders and communities involved in the hepatitis response and pledged continued support for Nigeria’s health agenda.
In a message delivered by the Technical Officer in Africa CDC, Titilola Munkail, the CDC official said:
“We are hopeful that Nigeria will continue to lead as it has always done in the elimination of harmful diseases, setting the pace for others to follow.”
National Coordinator of the National AIDS and STDs Control Programme, Dr. Adebobola Bashorun, noted that Project 365 was focused on testing, treatment, and vaccination in all communities and constituencies, in partnership with the National Assembly.
He emphasized the importance of community mobilization, using advocacy, media, and education to raise awareness about Hepatitis B and C, which are primarily transmitted through unprotected sex, blood contact, and other infected body fluids.
He advised preventive measures including abstinence, fidelity, and condom use:
“You have to be faithful, and of course, do use a condom when you need to have sexual relations with anybody, because the mode of transmission of Hepatitis B and C is very closely related and linked to other blood-borne diseases, such as HIV. So the approach is to ensure that you prevent transmission. For those who are infected, there is a curable treatment for hepatitis C. But for Hepatitis B, there is no treatment, but there are drugs that can moderate the rapidity of the development of chronic Hepatitis B infection in an individual after a full test has been done to determine whether it is an ongoing infection or a long-term chronic infection.”
